IMS

By Tom Sullivan September 6, 2016
Pokemon Go fever seems to be abating a bit as summer winds down. Already, the game that was once hailed as the most effective health app ever is on the verge of downslide. So the rising question for private and public health professionals, executives and entrepreneurs watching the apps' rapid rise and quick decline: What does Pokemon Go reveal about the fate of so many other health apps, fitness...
By Jonah Comstock September 17, 2015
There are more than twice as many health apps as there were in 2013, but whether those apps are better tools for doctors and patients is a mixed bag: while apps today are more likely than two years ago to connect to another device or wearable and more likely to connect to social media, they are no more likely to connect to provider systems or to have more than one function, according to a new...
By Jonah Comstock June 18, 2015
Personalized medicine was a hot topic at the BIO conference in Philadelphia, but in a session on digital health and patient engagement, payer and provider panelists also talked about how, in order to really drive medication and treatment adherence, patient engagement also has to be personalized. "You have to understand what are they worried about, what are their fears, what are they trying to do...
By Aditi Pai May 27, 2015
Danbury, Connecticut-based IMS Health, a multinational big data and analytics company, has partnered with Quantia, developer of a web and mobile community for physicians. Through this partnership, Quantia will provide the 225,000 members on its network with access to IMS’ app curation platform, AppScript. “QuantiaMD is designed to help physicians make better clinical decisions for their patients...
By Jonah Comstock June 18, 2014
The FDA has, at long last, released draft guidance for how pharmaceutical companies should behave on limited-character social media platforms like Twitter and when correcting misinformation on third-party sites. The FDA carefully controls labeling, advertisement, and promotion for drugs and devices requiring FDA clearance. It makes sure that companies never list the benefits of a drug without...
By Jonah Comstock January 21, 2014
A new report from IMS Health on the use of social media by pharmaceutical companies finds that among the top 50 pharmaceutical companies, half don't engage with consumers and patients through social media. But of those that do, IMS found that Johnson & Johnson emerged as a clear leader. It scored a 70 on IMS's Social Media Engagement Index. The next highest score, from GlaxoSmithkline, was...
By Jonah Comstock February 14, 2013
According to new data released by research firm InMedica, the American telehealth market is predicted to grow by 600 percent between 2012 and 2017. While there are currently 227,000 US telehealth patients, according to InMedica, that figure is forecast to reach up to 1.3 million patients in 2017. US telehealth revenues, meanwhile, will jump from $174.5 million last year to $707.9 million in 2017...